Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-03-01
1994-07-19
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
053310004
ABSTRACT:
Methods and compositions are disclosed utilizing optically pure R(-) ketoprofen for the treatment of pain including, but not limited to, pain associated with toothaches, headaches, sprains, joint pain and post-surgical pain, for example dental pain and ophthalmic pain, while substantially reducing adverse effects including, but not limited to, gastrointestinal, renal and hepatic toxicities, and leukopenia, which are associated with the administration of racemic ketoprofen. Optically pure R(-) ketoprofen is also useful in treating pyrexia while substantially reducing the adverse effects associated with the administration of racemic ketoprofen.
REFERENCES:
patent: 3641127 (1972-02-01), Farge et al.
patent: 4868214 (1989-09-01), Sunshine et al.
patent: 4927854 (1990-05-01), Sunshine et al.
patent: 4962124 (1990-10-01), Sunshine et al.
patent: 4973745 (1990-11-01), Blaschke et al.
patent: 5057427 (1991-10-01), Wald et al.
patent: 5114714 (1992-05-01), Young et al.
patent: 5114715 (1992-05-01), Young et al.
March, Advanced Organic Chemistry, 2nd. ed., "Methods of Resolution & Optical Purity", 1977, pp. 108-113.
Brune et al., "Aspirin-like Drugs May Block Pain Independently of Prostaglandin Synthesis Inhibition," Experientia 47: 257-261 (1991).
Honda et al., "Studies on the Metabolic Fate of Etodolac, (IV), Stereoselective Disposition of Etodolac in Rats," Iyakuhin Kenkyu 22(1): 147-151 (1991).
Brocks and Jamali, "The Pharmacokinetics of Etodolac Enantiomers in the Rat," Drug Metabolism and Disposition 18(4): 471-475 (1990).
Geisslinger et al., "Pharmacokinetics of S(+) and R(-) Ibuprofen in Rheumatoid Arthritis," European Journal of Clinical Pharmacology 38(5): 493-497 (1990).
Jamali et al., "Ketoprofen Pharmacokinetics in Humans: Evidence of Enantiomeric Inversion and Lack of Interaction," Journal of Pharmaceutical Sciences 79(5): 460-461 (1990).
Knihinicki et al., "Stereoselective Disposition of Ibuprofen and Flurbiprofen in Rats," Chirality 2: 134-140 (1990).
Muller et al., "Pharmacological Aspects of Chiral Nonsteroidal Anti-Inflammatory Drugs," Fundam Clin Pharmacol 4: 617-634 (1990).
Murray and Brater, "Nonsteroidal Anti-Inflammatory Drugs," Clinical Pharmacology 6(2): 365-397 (1990).
Sumi et al., "Acute Toxicity Study of Metabolites, Degradation Products, Impurity and Optical Isomers of Etodolac in Mice," Pharmacometrics (Oyo-Yakuri) 40(6): 737-746 (1990).
Williams, "Enantiomers in Arthritic Disorders," Pharmac. Ther. 46: 273-295 (1990).
Jamali et al., "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls," Journal of Pharmaceutical Sciences 78(9): 695-715 (1989).
Stechter, Handbook of Stereoisomers: Therapeutic Drugs, CRC Press Inc. 137-147 (1989).
Caldwell et al., "The Metabolic Chiral Inversion and Dispositional Enantioselectivity of the 2-Arylpropionic Acids and Their Biological Consequences," Biochemical Pharmacology 37(1): 105-114 (1988).
Foster et al., "Pharmacokinetics of Ketoprofen Enantiomers in Healthy Subjects Following Single and Multiple Doses," Journal of Pharmaceutical Sciences 77(1): 70-73 (1988).
Foster et al., "Pharmacokinetics of Ketoprofen Enantiomers in Young and Elderly Arthritic Patients Following Single and Multiple Doses," Journal of Pharmaceutical Sciences 77(3): 191-195 (1988).
Jamali, "Pharmacokinetics of Enantiomers of Chiral Non-Steroidal Anti-Inflammatory Drugs," European Journal of Drug Metabolism and Pharmacokinetics 13(1): 1-9 (1988).
Jamali et al., "Stereoselective Pharmacokinetics of Flurbiprofen in Humans and Rats," Journal of Pharmaceutical Sciences 77(8): 666-669 (1988).
Williams and Day, "The Contribution of Enantiomers to Variability in Response to Anti-Inflammatory Drugs," Anti-Rheumatic Drugs AAS 24: 76-84 (1988).
Abas and Meffin, "Enantioselective Disposition of 2-Arylpropionic Acid Nonsteroidal Anti-Inflammatory Drugs. IV/Ketoprofen Disposition," The Journal of Pharmacology and Experimental Therapeutics 240(2): 637-641 (1987).
Yamaguchi et al., "The Inhibitory Activities of 4580156-S and its Related Compounds on Prostaglandin Synthetase," Nippon Yakuriguky Zasshi 90: 295-302 (with English abstract) (1987).
Humber et al., "Etodolac (1,8-Diethyl-l,3,4,9-tetrahydropyranol [3,4-6]indole-l-acetic Acid): A Potent Anti-Inflammatory Drug. Conformation and Absolute Configuration of its Active Enantiomer," J. Med. Chem. 29: 871-874 (1986).
Singh et al., "Pharmacokinetics of the Enantiomers of Tiaprofenic Acid in Humans," Journal of Pharmaceutical Sciences 75(5): 43914 442 (1986).
Williams and Day, "Stereoselective Disposition-Basis for Variability in Response to NSAID's," Non-Steroidal Anti-Inflammatory Drugs Basis for Variability in Response AAS 17: 119-126 (1985).
Hutt and Caldwell, "The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory Drugs," Clinical Pharmacokinetics 9: 371-373 (1984).
Tamassia et al., "Pharmacokinetics of the enantiomers of Indoprofen in Man," Int. J. Clin. Pharm. Res. IV(3): 223-230 (1984).
Demerson et al., "Resolution of Etodolac and Anti-Inflamatory and Prostaglandin Synthetase Inhibiting Properties of the Enantiomers," J. Med. Chem. 26: 1778-1780 (1983).
Hutt and Caldwell, "The Metabolic Chiral Inversion of 2-arylprionic Acids-A Novel Route with Pharmacological Consequences," J. Pharm. Pharmacol. 35: 693-704 (1983).
Gray Nancy M.
Wechter William J.
Young James W.
Cintins Marianne M.
Jarvis William R. A.
Sepracor Inc.
LandOfFree
Antipyretic and analgesic methods and compositions containing op does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antipyretic and analgesic methods and compositions containing op, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipyretic and analgesic methods and compositions containing op will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-520279